aspergillosis – Page 2

Genotypic and Phenotypic Investigation of Clinical Aspergillus isolates from Iran Indicates Nosocomial Transmission Events of Aspergillus flavus

mycolabadmin

Researchers studied fungal infections caused by Aspergillus species in Iranian hospitals from 2020 to 2023. They found that Aspergillus flavus was the most common cause of infection and discovered evidence of several hospital-related outbreaks through genetic analysis. All isolates tested were susceptible to current antifungal medications, but the discovery of hospital transmission suggests the need for better infection control measures like improved air filtration in hospitals.

Global status and trends of invasive pulmonary aspergillosis: A bibliometric study

mycolabadmin

This study analyzes 24 years of research on invasive pulmonary aspergillosis, a serious fungal infection in immunocompromised patients. Using bibliometric tools, researchers mapped out how the field has evolved, identifying leading countries (USA, Germany, China), key experts like David Denning and Thomas Walsh, and shifting research focus from transplant-related infections to COVID-19-associated cases. The analysis shows the field is rapidly growing with increasing emphasis on rapid diagnostic methods and antifungal therapies.

Recent innovations and challenges in the treatment of fungal infections

mycolabadmin

Fungal infections are becoming more common and harder to treat due to drug resistance, especially in people with weakened immune systems. Current antifungal medications are becoming less effective because fungi are adapting to resist them, and these drugs can cause serious side effects. Scientists are developing new treatment strategies using combinations of existing drugs, engineered biological approaches, and specially designed delivery systems to overcome resistance and improve patient outcomes.

Time- and temperature-dependent Pentraxin 3 stability in serum and bronchoalveolar lavage fluid samples

mycolabadmin

Researchers tested how stable Pentraxin 3, a protein marker for fungal infections, remains when stored under different conditions. They found that samples stored in freezers at −20°C or −80°C kept stable for months, making Pentraxin 3 a reliable marker for diagnosing serious fungal infections. However, samples stored at warm temperatures degraded quickly, so proper cold storage is essential for accurate test results.

Azole Resistance in Aspergillus Species Isolated from Clinical Samples: A Nine-Year Single-Center Study in Turkey (2015–2023)

mycolabadmin

This study examined azole antifungal resistance in fungal infections from a Turkish hospital over nine years. Researchers tested 200 Aspergillus fungal isolates and found that 7% showed resistance to azole medications, with 11% of Aspergillus fumigatus showing resistance. The findings highlight the ongoing challenge of drug-resistant fungal infections and the importance of monitoring resistance patterns to improve treatment decisions for serious fungal infections.

Prevalence of fungi and their antifungal and disinfectant resistance in hospital environments: insights into combating nosocomial mycoses

mycolabadmin

This study examined how fungal infections spread in hospital settings by testing air and surfaces in Iranian hospital intensive care units. Researchers found that dangerous fungi like Aspergillus and Rhizopus were commonly present, especially in air ducts, and many of these fungi could resist common antifungal medications and disinfectants. The findings suggest that hospital environments serve as sources of infection for vulnerable patients and that better cleaning and air filtration systems are needed to protect hospitalized patients.

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile

mycolabadmin

Researchers in Chile studied serious mold infections in 176 hospitalized patients (adults and children) over two years. They found that aspergillosis (a lung infection caused by Aspergillus mold) was the most common, especially in patients whose immune systems were compromised by cancer, transplants, or medications. Interestingly, nearly 40% of cases also involved COVID-19 infection. Although almost all patients received antifungal medications, survival rates were concerning, with about one-third of patients still alive after six months.

Aspergillus Bronchitis at Localised Mucus Plug in an Immunocompetent Patient

mycolabadmin

A 55-year-old woman developed a rare fungal infection called Aspergillus bronchitis in a mucus plug within her lung over a 9-year period. Although she was otherwise healthy with a normal immune system, the fungus gradually grew and eventually caused serious bleeding in her lungs. Doctors treated the bleeding with artery embolization and then surgically removed the affected lung tissue. The fungus was identified as Aspergillus udagawae, a type that is harder to treat with standard antifungal medications.

The frequency distribution of Aspergillus section Nigri from clinical and environmental samples in Iran

mycolabadmin

Researchers studied black mold species (Aspergillus section Nigri) found in hospitals and the environment across Iran. They identified eight different species and found that certain types like A. welwitschiae were more common in ear infections while A. tubingensis was more prevalent in soil and air. These findings are important because some of these molds cause serious infections in humans and understanding where they live helps doctors predict and treat infections.

Identification of Non-fumigatus Aspergillus Species in Clinical Samples from Southern California

mycolabadmin

Researchers studied fungal infections caused by Aspergillus in Southern California from 2012 to 2023, examining over 10,000 patients. They found that species other than the commonly known A. fumigatus were actually more prevalent in clinical samples, particularly A. niger from skin and nail infections. Importantly, these non-fumigatus species showed seasonal patterns and some carry resistance to standard antifungal medications, suggesting doctors may need to adjust their treatment approaches for fungal infections.

Research Topic: aspergillosis